An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

Cited by (805)

Items 501–600 of 805

1. Avian Models for Human Carcinogenesis—Recent Findings from Molecular and Clinical Research
   Julia Niebora, Krzysztof Data, Dominika Domagała, Małgorzata Józkowiak, Saoirse Barrett, Tannaz Norizadeh Abbariki, Artur Bryja, Magdalena Kulus, Sławomir Woźniak, Hanna Ziemak et al. · 2024 · Cells
2. Comprehensive dissection of cis-regulatory elements in a 2.8 Mb topologically associated domain in six human cancers
   Christina M. Caragine, Victoria T. Le, Meer Mustafa, Bianca Jay Diaz, John A. Morris, Simon Müller, Alejandro Méndez‐Mancilla, Evan T. Geller, Noa Liscovitch‐Brauer, Neville E. Sanjana · 2025 · Nature Communications
3. Targeting FOXP1 phase separation in small cell lung cancer mechanisms of chemotherapy resistance
   Yichun Tang, Yuchun Niu, Yi Chen, Xuyang Zhou, Yueyang Hu, Lei Sun, Yan Xiong, Yue Xu, Qiongyao Wang, Yu Wang et al. · 2025 · Communications Biology
4. Recent Advances in Rapid and Highly Sensitive Detection of Proteins and Specific DNA Sequences Using a Magnetic Modulation Biosensing System
   Shira Roth, Michael Margulis, Amos Danielli · 2022 · Sensors
5. Aberrant transcription factors in the cancers of the pancreas
   Md. Hafiz Uddin, Md Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel F. El‐Rayes, Asfar Sohail Azmi · 2022 · Seminars in Cancer Biology
6. RETRACTED: Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
   Mariam Markouli, Dimitrios Strepkos, Christina Piperi · 2022 · International Journal of Molecular Sciences · Retracted
7. TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia
   Shi Hao Tan, Tze King Tan, Rui Yokomori, Minghui Liao, Xiao Zi Huang, Allen Eng Juh Yeoh, Takaomi Sanda · 2023 · Leukemia
8. A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins
   Robert R. West, Thomas R. Bauer, Laura M. Tuschong, Lisa J. Embree, Katherine R. Calvo, Desiree Tillo, Joie Davis, Steven M. Holland, Dennis D. Hickstein · 2023 · Blood Advances
9. Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
   Hyunsoo Kim, Kamila Wiśniewska, Matthew J. Regner, Aatish Thennavan, Philip M. Spanheimer, Hector L. Franco · 2023 · International Journal of Molecular Sciences
10. Three‐Dimensional Chromosomal Landscape Revealing miR ‐146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR‐Mediated Approach to Inhibit the Interferon Pathway
    Xinyi Zhu, Yutong Zhang, Zihang Yin, Zhizhong Ye, Yuting Qin, Zhaorui Cheng, Yiwei Shen, Zhihua Yin, Jianyang Ma, Yuanjia Tang et al. · 2023 · Arthritis & Rheumatology
11. Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemia
    Thomas A. Milne · 2024 · Current Opinion in Genetics & Development
12. Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia
    Stefan Nagel, Claudia Pommerenke, Corinna Meyer, Roderick A.F. MacLeod, Hans Günter Drexler · 2020 · PLoS ONE
13. WEVar: a novel statistical learning framework for predicting noncoding regulatory variants
    Ye Wang, Yuchao Jiang, Bing Yao, Kun Huang, Yunlong Liu, Yue Wang, Xiao Qin, Andrew J. Saykin, Li Chen · 2021 · Briefings in Bioinformatics
14. Super-Enhancers Dysregulations in Hematological Malignancies
    Yannis Belloucif, Camille Lobry · 2022 · Cells
15. THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours
    Jianyi Sun, Qiang Zhang, Xiangfei Sun, Anwei Xue, Xiaodong Gao, Kuntang Shen · 2022 · Cell Communication and Signaling
16. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia
    Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa · 2023 · Oncogene
17. Enhancers and their dynamics during hematopoietic differentiation and emerging strategies for therapeutic action
    Alba Cico, Charlotte Andrieu‐Soler, Éric Soler · 2016 · FEBS Letters
18. Copy number-aware deconvolution of tumor-normal DNA methylation profiles
    Elizabeth Larose Cadieux, Nana Mensah, Carla Castignani, Miljana Tanić, Gareth A. Wilson, Michelle Dietzen, Pawan Dhami, Heli Vaikkinen, Annelien Verfaillie, Cristina Cotobal et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
19. Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes
    Gavriel Fialkoff, Nobuyuki Takahashi, Israa Sharkia, Jenia Gutin, Nadav Hermoni, Rajesh Kumar, Lőrinc Sándor Pongor, Samantha Nichols, Linda C. Sciuto, Chante Graham et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
20. Towards functional maps of non-coding variants in cancer
    Yihan Wang, Gary C. Hon · 2024 · Frontiers in Genome Editing
21. Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by recruiting transcription factors CTCF and KLF15
    Yuchun Niu, Yichun Tang, Feng Ma, Xuyang Zhou, Yi Chen, Yu Wang, Yue Xu, Lei Sun, Shaoqiang Liang, Jianqi Yang et al. · 2024 · Oncogene
22. Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients
    Alastair Smith, Nicholas Denny, Catherine Chahrour, Kim Sharp, Marta Arachi, Ana M. Dopico-Fernandez, Natalina Elliott, Joe R. Harman, Thomas Jackson, Huimin Geng et al. · 2025 · Blood
23. Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia
    Patrícia Amaral, Rhona Christie, Daisy O. F. Gresham, Emma J M Lucas, Luyao Kevin Xu, Lena Behrmann, Jonathan Bond, Sofie Degerman, Frederik W. van Delft, Steven Goossens et al. · 2025 · Leukemia
24. Transcriptional circuitry atlas of genetic diverse unstimulated murine and human macrophages define disparity in population-wide innate immunity
    Bharat Mishra, Mohammad Athar, M. Shahid Mukhtar · 2021 · Scientific Reports
25. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
    Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Emilio Xodo, Claudio Brancolini · 2023 · International review of cytology
26. Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia
    Sunniyat Rahman, Gianna Bloye, Nadine Farah, Jonas Demeulemeester, Joana R. Costa, David O’Connor, Rachael Pocock, Tanya Rapoz-D’Silva, Adam Turňa, Lingyi Wang et al. · 2024 · Blood
27. PeakXus: comprehensive transcription factor binding site discovery from ChIP-Nexus and ChIP-Exo experiments
    Tuomo Hartonen, Biswajyoti Sahu, Kashyap Dave, Teemu Kivioja, Jussi Taipale · 2016 · Bioinformatics
28. dbInDel: a database of enhancer-associated insertion and deletion variants by analysis of H3K27ac ChIP-Seq
    Mo-Li Huang, Yun-Peng Wang, Manqiu Yang, Jun Yan, Henry Yang, Wen-Zhuo Zhuang, Ying Xu, H. Koeffler, D. Lin, Xi Chen · 2019 · Bioinform.
29. E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia
    Geoffrey Parriott, Barbara L. Kee · 2022 · Frontiers in Immunology
30. Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Eulàlia Genescà, Celia González‐Gil · 2022 · Cancers
31. Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant
    Lizelle Correia, R. Magno, J. Xavier, Bernardo P. de Almeida, I. Duarte, F. Esteves, Marinella N. Ghezzo, Matthew Eldridge, Chong Sun, A. Bosma et al. · 2021 · npj Breast Cancer
32. Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL
    David O’Connor, Jose Espejo Valle-Inclán, Lucía Conde, Gianna Bloye, Sunniyat Rahman, Joana R. Costa, Jack Luke Bartram, Stuart Paul Adams, Gary Wright, Hillary Elrick et al. · 2024 · Blood
33. Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing
    Keisuke Nimura, Yasufumi Kaneda · 2015 · Journal of Human Genetics
34. c-Myb regulates tumorigenic potential of embryonal rhabdomyosarcoma cells
    Petr Kašpar, Jan Procházka, Michaela Blažíková, Attila Juhasz, Vendula Novosadová, Radislav Sedláček · 2019 · Scientific Reports
35. RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia
    Md Rashedul Islam, Catherine E. Jenkins, Qi Cao, Jasper Wong, Misha Bilenky, Annaïck Carles, Michelle Moksa, Andrew P. Weng, Martin Hirst · 2023 · iScience
36. Novel oncogenic noncoding mutations in T-ALL
    Steven Goossens, Pieter Van Vlierberghe · 2017 · Blood
37. Beyond the coding genome non-coding mutations and cancer
    Dimple Notani · 2020 · Frontiers in bioscience
38. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers
    Jared M. Andrews, Sarah Pyfrom, Jennifer A. Schmidt, Olivia I. Koues, Rodney Kowalewski, Nicholas Grams, Jessica J. Sun, Leigh R. Berman, Eric James Duncavage, Yi-Shan Lee et al. · 2021 · EBioMedicine
39. Analysis of the landscape of human enhancer sequences in biological databases
    Juan Mulero-Hernández, Jesualdo Tomás Fernández‐Breis · 2022 · Computational and Structural Biotechnology Journal
40. Synthetic oleanane triterpenoids suppress MYB oncogene activity and sensitize T-cell acute lymphoblastic leukemia cells to chemotherapy
    Paloma Tejera Nevado, Tajana Tešan Tomić, Ali Atefyekta, André Fehr, Göran Stenman, Mattias K. Andersson · 2023 · Frontiers in Oncology
41. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia
    Jolynn Zu Lin Ong, Tze King Tan, Lu Wang, Shi Hao Tan, Takaomi Sanda · 2023 · Haematologica
42. A Functional Survey of the Regulatory Landscape of Estrogen Receptor–Positive Breast Cancer Evolution
    Iros Barozzi, Neil Slaven, Eleonora Canale, Rui Lopes, Inês Amorim Monteiro Barbosa, Melusine Bleu, Diana Ivanoiu, Claudia Pacini, Emanuela Mensa’, Alfie Chambers et al. · 2024 · Cancer Discovery
43. Histone profiles in cancer
    Simone Stefanie Riedel, Tobias Neff, Kathrin Maria Bernt · 2015 · Pharmacology & Therapeutics
44. Are super-enhancers regulators of regulatory genes of development and cancer?
    D. A. Didych, D. V. Tyulkina, Victor V. Pleshkan, И. В. Алексеенко, Eugene D. Sverdlov · 2015 · Molecular Biology
45. The Genome in a Three-Dimensional Context: Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer
    Llorenç Rovirosa, Alberto Ramos-Morales, Biola M. Javierre · 2020 · Frontiers in Immunology
46. Transcriptional Regulation of RUNX1: An Informatics Analysis
    Amarni Thomas, Judith Marsman, Jisha Antony, William S. Schierding, Justin Martin O'Sullivan, Julia A. Horsfield · 2021 · Genes
47. dbSUPER: a database of super-enhancers in mouse and human genome
    Aziz Khan, Xuegong Zhang · 2015 · bioRxiv (Cold Spring Harbor Laboratory)
48. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant Melanoma
    Mayinuer Maitituoheti, Emily Zhi-Yun Keung, Ming Tang, Yan Liang, Hunain Alam, Guangchun Han, Ayush T. Raman, Christopher J. Terranova, Sharmistha Sarkar, Elias Orouji et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
49. Leukemia core transcriptional circuitry is a sparsely interconnected hierarchy stabilized by incoherent feed-forward loops
    Taku Harada, Jérémie Kalfon, Monika W. Perez, Kenneth Eagle, Flora Dievenich Braes, Rashad Batley, Yaser Heshmati, Juliana M. Xavier-Ferrucio, Jazmin Ewers, Stuti Mehta et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
50. Dr.Nod: computational framework for discovery of regulatory non-coding drivers in tissue-matched distal regulatory elements
    Markéta Tomková, Jakub Tomek, Julie C. Chow, John D. McPherson, David Jay Segal, Fereydoun Hormozdiari · 2022 · Nucleic Acids Research
51. Genetic and Epigenetic Dysregulation of Transcriptional Enhancers in Cancer
    Giovanni A. Botten, Jian Xu · 2024 · Annual Review of Cancer Biology
52. Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing
    Rebecca C. Poulos, D. S. Perera, Deborah Packham, Anushi Shah, Caroline Janitz, John E. Pimanda, Nicholas John Hawkins, Robyn Lynne Ward, Luke B. Hesson, Jason W.H. Wong · 2019 · JNCI Cancer Spectrum
53. Functional annotation of noncoding mutations in cancer
    Husen Muhammad Umer, Karolina Smolińska, Jan Komorowski, Claes Wadelius · 2021 · Life Science Alliance
54. Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner
    Abhiruchi Biyanee, Maria V. Yusenko, Karl‐Heinz Klempnauer · 2022 · Cells
55. C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells
    Karl‐Heinz Klempnauer · 2023 · Oncotarget
56. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)
    Jolien De Bie, Julie Quessada, Giulia Tueur, Christine Lefebvre, Isabelle Luquet, Saloua Toujani, Wendy Cuccuini, Mårina Lafage‐Pochitaloff, Lucienne Michaux · 2023 · Current Research in Translational Medicine
57. Quantitative Trait Loci Identify Functional Noncoding Variation in Cancer
    Holger Heyn · 2016 · PLoS Genetics
58. The oncogene makes its escape
    Jeremiah A. Wala, Rameen Beroukhim · 2016 · Science
59. Glia maturation factor gamma, is a novel diagnostic marker of leukemia, has TAL1 binding sites in its promoter
    Saadiya Zia, Nudrat Baqri, Ramla Shahid · 2018 · Journal of King Saud University - Science
60. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome
    Saara Laukkanen, Laura Oksa, Atte Nikkilä, Mari Lahnalampi, Mataleena Parikka, Masafumi Seki, Junko Takita, Sofie Degerman, Charles Edo de Bock, Merja Heinäniemi et al. · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
61. Understanding super-enhancers
    Hao Cheng, Xiaoyang Dou, Jing‐Dong J. Han · 2016 · Science China Life Sciences
62. The chromatin of cancer
    Jussi Taipale · 2018 · Science
63. Rapid-kinetics degron benchmarking reveals off-target activities and mixed agonism-antagonism of MYB inhibitors
    Taku Harada, Monika W. Perez, Jérémie Kalfon, Flora Dievenich Braes, Rashad Batley, Kenneth Eagle, Behnam Nabet, Becky S. Leifer, Jasmin A. Kruell, Vikram R. Paralkar et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
64. Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development
    Robbin A. Nameki, Heidi S. Y. Chang, Pak Hin Yu, Forough Abbasi, Xianzhi Lin, Jessica Reddy, Marcela Haro, Marcos A. Fonseca, Matthew L. Freedman, Ronny Drapkin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
65. Transcription factor cooperativity at a GATA3 tandem DNA sequence determines oncogenic enhancer-mediated activation
    Joana R. Costa, Yang Li, Nurkaiyisah Zaal Anuar, David O’Connor, Sunniyat Rahman, Tanya Rapoz-D’Silva, Kent T.M. Fung, Rachael Pocock, Zhaodong Li, Stephen R Henderson et al. · 2025 · Cell Reports
66. Targeting super-enhancers in liver cancer: from pathogenic mechanisms to clinical applications
    Changlei Li, Zhiyuan Yao, Ao Sun, Jingyu Cao, Zusen Wang · 2025 · Frontiers in Pharmacology
67. Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma
    Jun Zhong, Aidan O’Brien, Minal B. Patel, Daina Eiser, Michael Mobaraki, Irene J. Collins, Li Wang, Konnie Guo, ThucNhi TruongVo, Ashley A. Jermusyk et al. · 2025 · Gut
68. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer
    Zhiyuan Yao, Peng Song, Wenjie Jiao · 2024 · Frontiers in Pharmacology
69. p53 exerts anticancer effects by regulating enhancer formation and activity
    Shuhan Chen, Xuchun Wang, Nan Yang, Yuechi Song, Cheng He, Yujie Sun · 2024 · Journal of Biomedical Research
70. MYB: A Key Transcription Factor in the Hematopoietic System Subject to Many Levels of Control
    Roza Berhanu Lemma, Bettina Maria Fuglerud, Jon Frampton, Odd S. Gabrielsen · 2024 · Advances in experimental medicine and biology
71. Liquid–liquid phase separation in hepatocellular carcinoma
    Jianguo Xu, Wangwang Liu, Yihan Yao, Tuomas P. J. Knowles, Zhigang Zhang, Yanli Zhang · 2024 · Frontiers in Cell and Developmental Biology
72. MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia
    Miriam Frech, Sabine Teichler, Christine Feld, Caroline Bouchard, Hannah Berberich, Katharina Sorg, Marco Mernberger, Lars Bullinger, Uta‐Maria Bauer, Andreas Neubauer · 2018 · Oncotarget
73. Characterization of the MYB-inhibitory potential of the Pan-HDAC inhibitor LAQ824
    Maria V. Yusenko, Karl‐Heinz Klempnauer · 2021 · BBA Advances
74. Detection of rare genetic variations in the promoter regions of the ATG16L gene in Parkinson's patients
    Ana Gómez-Martín, José Manuel Fuentes, J. Jordán, María Francisca Galindo, José Luis Fernández-García · 2023 · Neuroscience Letters
75. The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
    Yungang Hu, Qingqing Yang, Shuzhou Cai, Wei Ting Wang, Shiyin Fu · 2023 · Frontiers in Genetics
76. Molecular dynamics simulation reveals DNA-specific recognition mechanism via c-Myb in pseudo-palindromic consensus of mim-1 promoter
    Jinru Weng, Shuo Yang, Jinkang Shen, Hongsen Liu, Yuzi Xu, Dongyun Hao, Shan Wang · 2023 · Journal of Zhejiang University SCIENCE B
77. Diet-induced rewiring of the Wnt gene regulatory network connects aberrant splicing to fatty liver and liver cancer in DIAMOND mice
    Ana Rosa López-Pérez, Silvia Remeseiro, Andreas Hörnblad · 2023 · Scientific Reports
78. MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML
    Mary L. Clarke, Odd S. Gabrielsen, Jon Frampton · 2024 · Advances in experimental medicine and biology
79. Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axis
    Yunlu Jia, Yongxia Chen, Ming Chen, Mengye He, Suzhen Xu, Han Li, Xuanyi Lin, Linbo Wang, Jichun Zhou, Peng Shen et al. · 2024 · Cancer Letters
80. The roles of enhancer, especially super-enhancer-driven genes in tumor metabolism and immunity
    Shouwu Guo, Lu Zhang, Jiao Ren, Zhong Lü, Xiaolin Ma, Xinling Liu, Hongchuan Jin, Jiaqiu Li · 2025 · International Journal of Biological Macromolecules
81. Transcriptional Dynamics at Brain Enhancers: from Functional Specialization to Neurodegeneration
    Marit Willemijn Vermunt, Menno P. Creyghton · 2016 · Current Neurology and Neuroscience Reports
82. No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
    Emanuele Vitale, Mila Gugnoni, Alessia Ciarrocchi · 2021 · Cancers
83. Protein Phase Separation: New Insights into Carcinogenesis
    Yan Luo, Shasha Xiang, Jianbo Feng · 2022 · Cancers
84. Mapping regulatory elements
    Yuexin Zhou, Wensheng Wei · 2016 · Nature Biotechnology
85. Intrinsic Molecular Processes: Impact on Mutagenesis
    Byungho Lim, Jihyeob Mun, Seon‐Young Kim · 2017 · Trends in cancer
86. Epigenetics and Epigenomics
    Jennifer Wu, Myles A Brown · 2017 · Elsevier eBooks
87. Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome
    Adrián Mosquera Orgueira, Beatriz Antelo Rodríguez, José Ángel Díaz Arias, Nicolas A Diaz Varela, Natalia Alonso Vence, Marta Sonia González, Jose Luís Bello López · 2020 · Scientific Reports
88. Lineage transcription factors co-regulate subtype-specific genes providing a roadmap for systematic identification of small cell lung cancer vulnerabilities
    Karine Pozo, Rahul Krishna Kollipara, Demetra P. Kelenis, Kathia E. Rodarte, Xiaoyang Zhang, John Dorrance Minna, Jane E. B. Johnson · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
89. Current progress and future perspective of super-enhancers: a viable and effective bridge between the transcriptional apparatus and disease
    Ran Wang, Aiying Li, Zongran Pang · 2025 · Frontiers in Genetics
90. Super-enhancer DNA methylation in cancer: the mechanism of action and therapeutic directions
    Yue Bi, Kang Zou, Ke Wang · 2025 · Frontiers in Oncology
91. CRISPR/Cas9 Approaches to Investigate the Noncoding Genome
    Davide Seruggia, Lluı́s Montoliu · 2016 · Springer eBooks
92. Decoding Human Genome Regulatory Features That Influence HIV-1 Proviral Expression and Fate Through an Integrated Genomics Approach
    Holly Ruess, Jeon Lee, Carlos Guzman, Venkat S. Malladi, Iván D’Orso · 2022 · Bioinformatics and Biology Insights
93. MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape
    Roza Berhanu Lemma, Marit Ledsaak, Bettina Maria Fuglerud, Fernando Rodríguez-Castañeda, Ragnhild Eskeland, Odd S. Gabrielsen · 2023 · Journal of Biological Chemistry
94. Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes
    Michael Pudjihartono, Nicholas Pudjihartono, Justin Martin O'Sullivan, William S. Schierding · 2024 · British Journal of Cancer
95. Mechanisms of enhancer‐driven oncogene activation
    Joyce Vriend, Ruud Delwel, Dorien Pastoors · 2025 · International Journal of Cancer
96. Super-enhanced
    Sarah E. Seton-Rogers · 2014 · Nature reviews. Cancer
97. Transcriptional and epigenetic insights from stem cells and developing tissues
    Daniel A. Lim · 2015 · Development
98. Pathobiology of Acute Lymphoblastic Leukemia
    Melissa Burns, Scott A. Armstrong, Alejandro Gutiérrez · 2017 · Elsevier eBooks
99. Differentiated super-enhancers in lung cancer cells
    Xin Li, Chengjun Lu, Qijue Lu, Chunguang Li, Ji Jun Zhu, Tiejun Zhao, Hezhong Chen, Hai Dan Jin · 2019 · Science China Life Sciences
100. Applications of probability and statistics in cancer genomics
     Xiaotu Ma, Sasi Arunachalam, Yanling Liu · 2020 · Quantitative Biology